TCF7L2 Involvement in Estradiol- and Progesterone-Modulated Islet and Hepatic Glucose Homeostasis

Fengqin Dong,Qi Ling,Dan Ye,Zhe Zhang,Jing Shu,Guoping Chen,Yang Fei,Chengjiang Li
DOI: https://doi.org/10.1038/srep24859
IF: 4.6
2016-01-01
Scientific Reports
Abstract:To evaluate the role of TCF7L2, a key regulator of glucose homeostasis, in estradiol (E-2) and progesterone (P-4)-modulated glucose metabolism, mouse insulinoma cells (MIN6) and human liver cancer cells (hepG2 and HUH7) were treated with physiological concentrations of E-2 or P-4 in the up-and down-regulation of TCF7L2. Insulin/proinsulin secretion was measured in MIN6 cells, while glucose uptake and production were evaluated in liver cancer cells. E-2 increased insulin/proinsulin secretion under both basal and stimulated conditions, whereas P-4 increased insulin/proinsulin secretion only under glucose-stimulated conditions. An antagonistic effect, possibly concentration-dependent, of E-2 and P-4 on the regulation of islet glucose metabolism was observed. After E-2 or P-4 treatment, secretion of insulin/proinsulin was positively correlated with TCF7L2 protein expression. When TCF7L2 was silenced, E-2- or P-4-promoted insulin/proinsulin secretion was significantly weakened. Under glucotoxicity conditions, overexpression of TCF7L2 increased insulin secretion and processing. In liver cancer cells, E-2 or P-4 exposure elevated TCF7L2 expression, enhanced the activity of insulin signaling (pAKT/pGSK), reduced PEPCK expression, subsequently increased insulin-stimulated glucose uptake, and decreased glucose production. Silencing TCF7L2 eliminated effects of E-2 or P-4. In conclusion, TCF7L2 regulates E-2- or P-4-modulated islet and hepatic glucose metabolism. The results have implications for glucose homeostasis in pregnancy.
What problem does this paper attempt to address?